These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32144438)

  • 1. Tripping on nothing: placebo psychedelics and contextual factors.
    Olson JA; Suissa-Rocheleau L; Lifshitz M; Raz A; Veissière SPL
    Psychopharmacology (Berl); 2020 May; 237(5):1371-1382. PubMed ID: 32144438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.
    O'Callaghan C; Hubik DJ; Dwyer J; Williams M; Ross M
    J Music Ther; 2020 Jul; 57(3):282-314. PubMed ID: 32227084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
    Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS
    Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hidden therapist: evidence for a central role of music in psychedelic therapy.
    Kaelen M; Giribaldi B; Raine J; Evans L; Timmerman C; Rodriguez N; Roseman L; Feilding A; Nutt D; Carhart-Harris R
    Psychopharmacology (Berl); 2018 Feb; 235(2):505-519. PubMed ID: 29396616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW; Bates LW; Hendricks PS
    J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology, Structure, and Dynamic of Psychedelic States.
    Preller KH; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():221-256. PubMed ID: 28025814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.
    Carbonaro TM; Johnson MW; Hurwitz E; Griffiths RR
    Psychopharmacology (Berl); 2018 Feb; 235(2):521-534. PubMed ID: 29116367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.
    Carbonaro TM; Johnson MW; Griffiths RR
    Psychopharmacology (Berl); 2020 Aug; 237(8):2293-2304. PubMed ID: 32500212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics and music: neuroscience and therapeutic implications.
    Barrett FS; Preller KH; Kaelen M
    Int Rev Psychiatry; 2018 Aug; 30(4):350-362. PubMed ID: 30240282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD enhances the emotional response to music.
    Kaelen M; Barrett FS; Roseman L; Lorenz R; Family N; Bolstridge M; Curran HV; Feilding A; Nutt DJ; Carhart-Harris RL
    Psychopharmacology (Berl); 2015 Oct; 232(19):3607-14. PubMed ID: 26257162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
    Schartner MM; Carhart-Harris RL; Barrett AB; Seth AK; Muthukumaraswamy SD
    Sci Rep; 2017 Apr; 7():46421. PubMed ID: 28422113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out of the box: A psychedelic model to study the creative mind.
    Kuypers KPC
    Med Hypotheses; 2018 Jun; 115():13-16. PubMed ID: 29685188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.
    Kaertner LS; Steinborn MB; Kettner H; Spriggs MJ; Roseman L; Buchborn T; Balaet M; Timmermann C; Erritzoe D; Carhart-Harris RL
    Sci Rep; 2021 Jan; 11(1):1941. PubMed ID: 33479342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
    Stenbæk DS; Madsen MK; Ozenne B; Kristiansen S; Burmester D; Erritzoe D; Knudsen GM; Fisher PM
    J Psychopharmacol; 2021 Apr; 35(4):459-468. PubMed ID: 33501857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic use and intimate partner violence: The role of emotion regulation.
    Thiessen MS; Walsh Z; Bird BM; Lafrance A
    J Psychopharmacol; 2018 Jul; 32(7):749-755. PubMed ID: 29807492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.